
    
      All adult participants will receive a single injection of study vaccine or placebo. After
      satisfactory safety evaluation, toddler participants will receive a single injection of study
      vaccine or placebo. After satisfactory safety evaluation, infant participants will receive 3
      injections of study vaccine or placebo in dose-ascending order (low, medium, and high dose),
      with a safety evaluation after each dose level before the study proceeds to the next higher
      dose. All participants will undergo immunogenicity testing and monitoring for safety.
    
  